South Wales, Dec. 1 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "BrightTrack" on Nov. 17. The details about the trademark application no. UK00004295961 published in the journal no. 2025/048 (Nov. 28).
With Trademark Brothers Ltd. as representative, PHLO TECHNOLOGIES LTD filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Downloadable mobile applications for supporting users prescribed GLP-1 receptor agonists through tools such as dose scheduling, injection tracking, side effect logging, and weight monitoring; Downloadable software for collecting and analysing biometric data for use in personal health management, including nutrition tracking, sleep analytics, physical activity monitoring, and metabolic performance; Wearable-compatible software for monitoring and interpreting health markers relevant to chronic disease management, preventative care, and lifestyle optimisation; Downloadable databases and AI-driven digital tools for longitudinal health tracking and predictive wellness modelling; Downloadable electronic publications and digital content relating to GLP-1 therapies, weight loss, lifestyle change, and longevity science.
Class 41 : Provision of online non-downloadable training, educational programmes, and content in the fields of obesity management, GLP-1 medication use, nutrition, physical activity, behavioural health, and longevity; Delivery of virtual and in-person workshops, coaching sessions, and self-guided learning modules focused on habit formation, mental resilience, healthy ageing, and preventative healthcare; Publishing of digital articles, expert-led videos, and multimedia content relating to health optimisation, therapeutic interventions, fitness, and personalised lifestyle interventions; Production and distribution of podcasts featuring expert discussions, patient stories, and interviews in the fields of metabolic health, digital health, pharmacotherapy, and lifestyle medicine; Organisation and hosting of webinars, seminars, and conferences relating to obesity science, pharmaceutical innovation, digital health solutions, and the advancement of preventative and personalised healthcare.
Class 42 : Software as a Service (SaaS) featuring adaptive AI systems for personalised health planning, integrating GLP-1 medication support with lifestyle analytics, digital diagnostics, and predictive modelling; Platform as a Service (PaaS) featuring a configurable digital infrastructure for third-party integration of health tools, diagnostics services, and personalised wellness modules; Design and development of cloud platforms for medical and wellness data integration, including user health dashboards, longitudinal data visualisation, and clinician interfaces; Hosting of mobile and web-based platforms offering real-time feedback, behavioural prompts, and health metric tracking; Research and development in the fields of digital therapeutics, metabolic health technologies, longevity algorithms, and chronic disease prevention; Data analytics services using health trends to provide personalised recommendations across nutrition, physical activity, medication compliance, and wellness optimisation.
Class 44 : Provision of healthcare and wellness services via a digital platform including GLP-1 medication support, weight loss consultations, and metabolic health reviews; Personalised health planning and tele-health consultations incorporating diagnostics, wearable data, lifestyle modification programmes, and preventative screening pathways; Nutrition and wellness coaching informed by user-specific biomarker data and behaviour profiles; Medical services in the fields of lifestyle medicine, endocrinology, sleep health, physical performance, and healthy ageing; Digital access to clinical expertise, including provision of therapeutic pathways for obesity, type 2 diabetes, and preventative medicine through pharmacological and non-pharmacological means; Conducting and interpreting laboratory and genetic testing for health assessment, disease risk profiling, and personalised treatment planning; AI-supported triage, symptom checking, and health insights to guide care decisions and behavioural interventions; Provision of integrative and functional health services including gut health, hormone optimisation, and anti-ageing treatments; Remote patient monitoring and health reporting services for chronic condition management and wellness tracking; Coordination of health services by connecting users to a network of physicians, dietitians, health coaches, and diagnostics providers through a centralised digital platform.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004295961
Disclaimer: Curated by HT Syndication.
